Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Dear editor Hereby we submit our work entitled “Combination of Q-Switched Nd:YAG and Fractional Erbium:YAG Lasers in Treatment of Melasma: a Randomized Controlled Clinical Trial” to Journal of Lasers in Medical Sciences for review and possible publication. By submitting this manuscript, we transfer all the publications right and copy right to Journal of Lasers in Medical Sciences. This work has not been published before or presented in any dermatology or cosmetic surgery congress. All authors participated in conducting the study and preparing final manuscript and met eligibility for authorship according to ICMJE. This study has received no grant or financial support and the authors declare no conflict of interest. The summary of our work is provided below: Ablative and nonablative lasers have been used alone or in combination to treat pigmentary diseases such as melasma. For the first time, we employed a combination of Q-switched Nd:YAG and fractional erbium:YAG lasers along with topical treatment to improve melasma lesions. Before treatment and one month after four therapy sessions held every other week, we objectively assessed the color changes, melanin contents, and erythema intensity through biometric devices and achieved significant improvement with treatment by both laser systems than with Q-switched Nd:YAG laser alone. I am available for any questions and I hope that we would have a chance to publish our work with you. Sincerely Mohammadali Nilforoushzadeh, MD Associate Professor of Dermatology Skin and Stem Cell Research Center, Tehran University of Medical Sciences, Tehran, Iran